Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.5.0.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Statements of Operations [Abstract]        
Revenue
Operating expenses:        
Research and development, net of reimbursements 5,685,777 2,828,093 13,599,174 10,714,766
General and administrative 1,394,910 1,794,901 6,363,825 9,151,667
Depreciation expense 20,078 16,820 57,670 43,409
Total operating expenses 7,100,765 4,639,814 20,020,669 19,909,842
Loss from operations (7,100,765) (4,639,814) (20,020,669) (19,909,842)
Other income (expense):        
Interest expense (666) (588) (5,007) (7,868)
Gain (loss) on change in fair value of derivative liabilities 502,778 694,208 2,399,639 5,432,918
Total other income (expense) 502,112 693,620 2,394,632 5,425,050
Net loss $ (6,598,653) $ (3,946,194) $ (17,626,037) $ (14,484,792)
Net loss per common share - basic $ (0.14) $ (0.1) $ (0.38) $ (0.39)
Net loss per common share - diluted $ (0.14) $ (0.1) $ (0.38) $ (0.39)
Weighted average common shares outstanding - basic 47,651,906 41,167,352 46,126,928 37,069,779
Weighted average common shares outstanding - diluted 47,651,906 41,167,352 46,126,928 37,069,779